Dr. Harris has extensive experience as a clinician, prescriber and drug developer. He has served as a clinical investigator for numerous dermatology NDAs and ANDAs and as a clinical advisor to multiple Contract Research Organizations. A board-certified dermatologist and a fellow of the American Society of Mohs Surgery (ASMS), Dr. Harris also has in-depth training in skin cancer treatment, wound healing and cosmetic procedures. Dr. Harris graduated from Florida State University and obtained his doctorate from the University of Florida Medical School. He trained at the Mayo Clinic in Rochester, MN, before completing his dermatology residency at the University of Miami. To view publications by Dr. Harris, Click Here
Rob joined Harris Pharmaceutical in October 2017 as a Director and was responsible for commercial and operational activities, business development and financial analysis. In 2020, Rob was promoted to President and COO where he is dedicated to expanding Harris' predominantly dermatological focus by bringing new products into the portfolio that continue to emphasize safety and effectiveness while helping patients with various skin conditions. Rob holds a Bachelor of Science in Accounting from Rutgers University and is a Certified Public Accountant.
Mina Buenafe is the Head of Quality and Regulatory Affairs, bringing with her over 25 years of experience in Pharmaceutical Product Development, R&D, Quality, and Regulatory Affairs. She has co-authored several US and international patents on inhalation products development. Mina joined the company in 2018, working on the regulatory side of the business, but has since expanded her role to include responsibilities in Quality Management. She holds an undergraduate and graduate degree in Chemistry with focus on Physical and Synthetic Organic Chemistry.